A B S T R A C T A simple method is described for the measurement of p H changes in hemoglobin solutions on oxygenation and reduction. Data are presented establishing the absence of a Bohr effect in p-chloromercuribenzoate [PCMB] treated hemoglobin.
INTRODUCTION
When a solution of hemoglobin is oxygenated, it becomes more acidic (I). Conversely, the oxygen affinity of a hemoglobin solution is lowered by increasing its hydrogen ion concentration (2) . Related to these properties of hemoglobin is the fact that when blood is exposed to high CO 2 pressures, its affinity for oxygen decreases. The latter phenomenon was discovered by Bohr in 1904 and is generally known as the "Bohr effect." In more recent years the term Bohr effect has been used to designate all the aforementioned properties of hemoglobin (3, 4) . Experimental evidence has been presented by Riggs (3) and Benesch (4) to show that this effect, in one or the other of its aspects, can be modified by the addition of reagents to hemoglobin solutions. There has been no previous report of the preparation of a hemoglobin solution in which the Bohr effect has been abolished by addition of a specific reagent, the resulting hemoglobin still retaining its full capacity to combine reversibly with oxygen. We are reporting the preparation of such a hemoglobin. Data concerning the results of the addition of a number of sulfhydryl reagents to hemoglobin are also reported, together with an interpretation which may assist in identifying the acidic groups whose dissociation is responsible for the Bohr effect. 889
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M E T H O D S
Preparation of Hemoglobin Blood was obtained from an adult Dorset sheep, the same animal being used throughout. The blood was drawn into an oiled, heparinized syringe and the cells were separated by centrifugation. After washing 5 times with 0.9 per cent sodium chloride, the ceils were lysed by freezing on solid carbon dioxide and thawing. The cell debris was removed by centrifugation at 5000 X g in a Spinco ultracentrifuge at 3 °C. for 10 minutes. The resulting hemoglobin solution was decanted and filtered through activated charcoal in the cold room at 5°C. The oxygen contents of hemoglobin solutions were measured on 1.0 ml. samples by the method of Van Slyke and Neill (5) . The hemoglobin concentration of a solution was determined by measuring its oxygen content after equilibration with air and subtracting from this figure the content of physically dissolved oxygen. The same concentration of hemoglobin was used in all experiments.
Determinations of Bohr Effect by Measurement of pH
The changes in acidity of hemoglobin solutions accompanying oxygenation and reduction were observed by means of a glass electrode attached to a radiometer p H meter, model T I ' T la. 5 ml. portions of a 2 per cent (w/v) hemoglobin solution and approximately 0.02 ml.
of Dow Coming anti-foam compound B were placed in a closed vessel of approximate volume 12 ml. and were successively oxygenated and reduced by bubbling a stream of first air, then nitrogen, freed from carbon dioxide by passage through an aqueous solution of potassium hydroxide. Approximately 15 minutes were required in each oxygenation or reduction for the p H of the hemoglobin solution to come to a steady value. Each result listed in Tables II and I I I is the mean of at least four consecutive oxygenation-reduction cycles in which the greatest observed deviation in p H change was 10 per cent of the mean. All incubations with the reagents and all measurements of p H were performed at a constant temperature of 22 °.
Measurement of Bohr Effect by Gasometric Analyses
To the stock hemoglobin solution (36 ml.), 4 ml. of 1 M phosphate buffer were added; the pH of the mixture, as measured, was 7.60. The hemoglobin solution thus treated was divided into two equal aliquots. To one aliquot, 71.4 rag. of p-chloromercuribenzoate (PCMB) were added to a final concentration of 10 -2 M. The two solutions were kept for 15 minutes at room temperature. Four tonometers, 250 ml. capacity, were prepared with oxygen and nitrogen mixtures of known composition. One end of each tonometer was closed with a soft rubber stopper through which solutions could be injected and withdrawn anaerobically by means of a syringe and a hypodermic needle. Two tonometers each received 9 ml. of PCMB-treated hemoglobin; two, 9 ml. of untreated hemoglobin. The tonometers were then rotated for 30 minutes at 26°C. to achieve equilibration of the hemoglobins with the gas phases.
The PCMB-treated hemoglobin was equilibrated with oxygen at 10 mm. Hg pressure; the control hemoglobin, with oxygen at 5 ram. Hg pressure. These pressures were chosen on the basis of preliminary experiments which had shown that for these conditions of temperature and pH, the two hemoglobins would be about onehalf saturated with oxygen. After equilibration, 4.5 hal. samples were withdrawn from the tonometers for measurements of oxygen content and capacity. In each remaining tonometer, 0.2 ml. of a sodium hydroxide solution was then injected to change the p H from 7.60 to 7.85, and the tonometers were rotated again to achieve equilibration with the gas phases under these new conditions. The amount of sodium hydroxide used was selected on the basis of preliminary experiments. The amount of oxygen in the tonometers was greatly in excess of the amount that the hemoglobins could bind at the higher pH; hence each experiment may be considered as being conducted at a constant oxygen pressure. After equilibration, a further 4.5 ml. of solution was withdrawn from each tonometer and analyzed for oxygen content and capacity.
Amino Acid Analysis of Hemoglobin Solutions
In each analysis 2 rnl. aliquots of solutions of hemoglobin previously treated with sulfhydryl reagents were centrifuged, then 1 ml. portions of the supernatant solutions were applied to a sephadex G-25 column, 30 cm. by 0.9 era., to remove excess reagent. Elution was performed at 25 ° with 50 per cent acetic acid at a flow rate of about 8 ml./hour; the protein separated from heine is not retarded under these conditions, and appears at exclusion volume. Appropriate fractions containing the protein were combined and were lyophilized. 10 rag. of dry residue were then treated with 2 ml. of 6 N hydrochloric acid and were maintained at 110 ° for 24 hours in an evacuated, sealed tube. Samples containing derivatives of N E M were hydrolyzed for 72 hours; these conditions of hydrolysis have been found necessary both by ourselves and by others (6) for an 85 per cent conversion of N-ethylsuccinimido-l-cysteine to 1-cysteinosuccinic acid. The hydrochloric acid was removed in vacuo on a rotary evaporator, and the resulting residue was treated with 0.5 ml. of water and with 0.5 ml. of 0.2 g sodium phosphate buffer of p H 6.5. This solution was maintained for 4 hours at 25 ° to complete oxidation of free sulfhydryl groups. To the resulting suspension was added 0.6 ml. of N hydrochloric acid, and aliquots of this solution containing about 4 rag. of amino acids were used in quantitative, automatic amino acid analysis (7) .
Performic acid oxidation of hemoglobin was carried out according to the method of Schram, Moore, and Bigwood (8) . The residual performic acid was decomposed by addition of an excess of sodium sulfite soludon at 0 ° (9), followed by hydrolysis in 6 N hydrochloric acid at 110 ° for 24 hours.
The preparation of hemoglobin used in these experiments has included very little purification; an indication of the presence of an impurity was provided by the appearance in acid hydrolysates of between 0.2 and 0.4 residues of isoleucine, an amino acid considered to be absent in purified sheep hemoglobins (10) . Calculation of the number of residues of cysteic acid and of modified cysteine derivatives was based on the amounts found relative to aspartic acid, 69 residues of which have been found per molecule in sheep hemoglobin I (10).
M A T E R I A L S
N-Ethylmaleimide (NEM) was purchased from Sigma Chemical Co., sodium parachloromercuribenzoate (PCMB) from Nutritional Biochemicals Co., 2, B-dimercaptopropanol (BAL) from Nutritional Biochemicals Co., iodoacetamide from Mann Research Laboratories, and iodoacetic acid from Eastman Chemical Co. Table I , the percentage saturation of hemoglobin with oxygen increases considerably by raising the pH from 7.60 to 7.85 under conditions in which the oxygen pressure is kept constant. Treatment of the hemoglobin with PCMB nearly abolishes this change. It must be noted that a change of per cent oxygen saturation from 67.8 to 69.7 is close to the limits of error of this method; more observations would be needed to establish its significance. Measurement of the Bohr effect by the gasometric technique 
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RESULTS
(a) Measurement of the Bohr Effect in PCMB-Treated Hemoglobin by Gasometric Analysis As shown in
T A B L E I T H E E F F E C T O F P H O N T H E O X Y G E N S A T U R A T I O N O F P C M B -T R E A T E D O X Y H E M O G L O B I N C
(b) Measurement of the Bohr Effect in PCMB-Treated Hemoglobin by pH Analysis
The influence of PCMB on the Bohr effect was confirmed also by measurement of pH as described above. 2.5 ml. of 4 per cent (w/v) aqueous oxyhemoglobin were mixed with 2.5 ml. of 2 ;< 10 -2 M PCMB at pH 7.5, and the pH of the resulting solution was adjusted to 7.2 by the addition of 0.1 N hydrochloric acid. Some precipitation of PCMB occurred. The solution was maintained for 15 minutes at 22 ° in a stream of air. pH values of the solution were then recorded after successive oxygenations and reductions; no change in p H was observed. A similarly treated hemoglobin solution, in which the PCMB solution was replaced by distilled water, exhibited a reversible pH change of 0.18 unit.
The above experiment was repeated, substituting a 2.5 X I0 -~ M PCMB solution for the former 2 X 10 -2 M PCMB solution. Under the same condi-tions, the pH change was found to be 0.10 unit. Continued storage for 10 hours at 25 ° of this PCMB-treated oxyhemoglobin resulted in complete abolition of the pH change accompanying oxygenation and reduction. A control hemoglobin solution in which the addition of PCMB was omitted, maintained also for 10 hours at 25 °, gave on oxygenation and reduction a pH change of 0.12 unit.
The effect of reaction of oxyhemoglobin with an excess of PCMB was completely abolished by subsequent storage for 12 hours at 25 ° with an excess of dimercaptopropanol (BAL), followed by dialysis against distilled water. The data presented in Part b of the Results are summarized in Table  II .
(c) The Effect of Other Sulfhydryl Reagents
The addition of mercuric chloride (final concentration, 1.25 X 10 -8 M) to an oxyhemoglobin solution at pH 7.2 resulted in an immediate decrease in the Bohr effect; on increasing the concentration of mercuric ion to 2.5 X 10 -8 M, a reddish brown precipitate appeared and the solution slowly recovered a Bohr effect of the same order as a control hemoglobin solution. Treatment at pH 7.1 for I0 minutes at 22°C. of oxyhemoglobin with an excess of NEM (1 X 10 -2 M), resulted in a pH change on oxygenation and reduction of 0.03 unit. Analogous treatment of a control oxyhemoglobin solution lacking NEM gave a reversible pH change of 0. 18 unit. Further storage for 10 hours at 25°C. of the NEM-treated hemoglobin resulted in no further decrease in pH change. BAL, which restored the full Bohr effect in PCMB-treated hemoglobin, failed to do so with NEM-treated hemoglobin.
Quantitative amino acid analysis of performic acid--oxidized hemoglobin indicated the presence of 6. 1 residues of cysteic acid per molecule of hemoglobin. Amino acid analysis following acid hydrolysis of the hemoglobin treated with 10 -2 M N E M for 1 hour at 25 ° showed that 3.2 residues of cysteine per molecule of hemoglobin had undergone reaction, as indicated by deter- Analysis of hemoglobin treated with 10 -2 M iodoacetate for 12 hours at pH 7.1 and 25 ° showed that 2.3 residues of cysteine per molecule of hemoglobin had undergone reaction. Analysis of the same solution after 4 hours' incubation showed that 1.3 residues of cysteine had been modified. Oxyhemoglobin treated with 10 -2 ~ iodoacetate for 1 hour at 22°C. was maintained at pH 7.1 with 2.5 ml. of 2.0 X 10 -2 M NEM solution for 1 hour; a 20 per cent decrease in the magnitude of the reversible pH change was observed. Treatment of this solution with 2.5 ml. of 2 X 10 -2 M PCMB solution at pH 7.1 resulted in complete abolition of the Bohr effect.
T A B L E I I I T H E E F F E C T O F S U L F H Y D R Y L I N H I B I T O R S O N T H E O X Y G E N -L I N K E D P H C H A N G E S O F H E M O G L O B I N S O L U T I O N S C o n c e n t r a t i o n of
To an oxyhemoglobin solution, previously treated for 15 minutes with 2.5 ml. of 2 X 10 -~ M PCMB at pH 7.1, were added successive 0.1 ml. portions of a concentrated urea solution (1 gm./2 ml.). Additions were continued to a final urea concentration in the hemoglobin solution of 3.0 M. No recovery of the Bohr effect was detected.
The data presented in Part c are summarized in Table III .
D I S C U S S I O N
Considerable physiological significance has been ascribed to the pH change that occurs in a hemoglobin solution with oxygenation and reduction. This reversible change is brought about by alterations in the pK of a number of groups on the protein molecule (11), leading to a release of hydrogen ions with oxygenation. Conceivably, in a molecule as complex as a protein, the identification of groups whose presence is required for this pH effect will include groups in addition to the protein-releasing groups themselves. It is known that the berne components embedded in the protein structure of hemoglobin are considerably more accessible to reaction with oxygen after some preliminary oxygenation has occurred. Thus, oxygenation is considered to be accompanied by a structural change in the architecture of the protein component. It has been suggested that the Bohr effect occurs also as a result of such reversible changes in configuration (12) . These changes in tertiary structure of the protein would place the proton-releasing groups responsible for the Bohr effect in proximity with differing polar groups in the molecule; in this respect, the Bohr effect may be analogous to the change in pK of a weak acid which occurs with change in ionic strength of its solution. Furthermore, sulfhydryl groups of hemoglobin have been shown to be intimately involved in the mechanism of heme-heme interaction (13); thus, reaction of hemoglobin with sulfhydryl reagents modifies the changes in tertiary structure ordinarily associated with oxygenation. Hence, results obtained with these reagents in reducing the Bohr effect cannot be considered proof of the identity of the sulfhydryl groups of cysteine residues in hemoglobin with the proton-releasing groups.
On the basis of the effect of sulfhydryl inhibitors upon the oxygen disso-
" I96I ciation curves of hemoglobin solutions, and titrations of the SH groups in hemoglobins, Riggs (3) has stated that the sulfhydryl groups are the primary acidic groups linked with oxygenation. While we have confirmed the effect of certain sulfhydryl inhibitors in decreasing the Bohr effect, our experiments, in agreement with the observations of Benesch (4), show that oxyhemoglobin may be reacted with a large excess of both iodoacetate and then NEM, without significant change in the Bohr effect. Thus the "reactive" sulfhydryl groups of sheep hemoglobin are not the proton-releasing groups involved in the Bohr effect. However, it must be noted that under these conditions only 3 of the 6 sulfhydryl residues have undergone reaction.
Benesch (4) has reported that the SH-groups of human hemoglobin may be blocked with silver, mercury, or iodoacetamide without any change in the Bohr effect, whereas N E M reduces the effect to about one-half; previous blocking of sulfhydryl groups in hemoglobin by iodoacetamide prevented the influence of NEM. It was concluded that the anomalous behavior of N E M was the consequence not of its initial addition to a sulfhydryl group, but of a subsequent acylation of the true oxygen-linked acidic group, either imidazole or amino, by the imide ring of NEM.
Previous experiments on the chemistry of NEM (14) have shown that it undergoes a polymerization catalyzed by imidazole; no evidence was obtained for the survival of a stable product involving both N E M and imidazole. Furthermore, when N E M was allowed to react with the sulfhydryl group of thiolhistidine, no indication of a further chemical reaction between the imide ring of the product and the secondary imidazole nitrogen atom was obtained (15) . The proposal of an intramolecular acylation reaction between NEM, anchored to a sulfhydryl group in hemoglobin, and an imidazole group in close proximity is not supported by these experiments.
Model experiments using the addition products of cysteine, homocysteine, or glutathione with N E M (16) have shown that it is only in the cysteine adduct, where amino and sulfhydryl groups have been located in a sterically favorable position, that the imide ring is able to react intramolecularly with an adjacent amino group. At pH 8.5 and 30°C., the half-life period of this reaction with amino groups of pK 8.8 was found to be 2 hours. It is to be expected that the half-life time at pH 7.0 and at 20°C. of the analogous reaction proposed by Benesch, involving a peptide terminal amino group with a pK of approximately 8.0, would be in the region of 15 hours. Our experiments show that incubation of NEM in sufficient concentration to react with 4 of the 6 sulfhydryl groups of sheep hemoglobin causes a 50 per cent decrease in the Bohr effect within 10 minutes. Furthermore, we have found that complete abolition of the Bohr effect results from treatment of oxyhemoglobin with PCMB, presumably a monofunctional reagent. The action of NEM in diminishing the Bohr effect of hemoglobin thus does not appear to be explained by an intrarnolecular acylation reaction involving amino groups.
Our results, recorded in table III, show that incubation of hemoglobin separately with five different sulfhydryl inhibitors results in remarkably different reductions in the Bohr effect. We would propose the following interpretation. If, as seems likely, reaction of the sulfhydryl groups of hemoglobin with these different reagents results in correspondingly different spatial distributions of the peptide chains, then the new environment achieved by the repositioning of the proton-releasing groups in each case determines the extent to which these groups ionize further with oxygenation. Thus, all sulfhydryl inhibitors would not be expected to decrease the Bohr effect. In addition, any reagent capable either of reacting directly with the protonreleasing groups, or of altering critically the spatial configuration of the protein, could thereby alter the Bohr effect. The former possibility is suggested by the experiment in which oxyhemoglobin was treated with an excess of first iodoacetate and then NEM without significant change in the Bohr effect, followed by the addition of PCMB which completely abolished it. Under these conditions PCMB may undergo reaction with another chemical group, either the "unreactive" sulfhydryl groups or imidazole (17) , and it is one of these groups which is the primary proton-releasing center responsible for the Bohr effect.
Finally, mercuric ion, which in low concentration produced a considerable reduction in the Bohr effect, with increasing concentration caused a precipitation of hemoglobin. The Bohr effect of the supernatant solution was restored. A possible explanation is that initially, mercaptide formation occurs with an accompanying change in spatial configuration of the protein and a consequent reduction in the Bohr effect. On increasing the concentration of added mercuric ion, denaturation and precipitation of some of the protein occur. Mercuric ion is coprecipitated, involving a reversal of the initial mercaptide formation, and the Bohr effect of the remaining native hemoglobin is partially restored.
To establish these interpretations concerning the effect of sulfhydryl inhibitors on hemoglobin on a firmer basis, further analytical work involving degradation of the modified hemoglobin molecules is required to determine the location of those chemical groups that undergo reaction with these reagents. The availability of a hemoglobin whose Bohr effect has been completely abolished by treatment with PCMB may prove of value in further studies. 
